10-Q: Trans American Aquaculture Reports Q1 2024 Results, Revenue Increases but Losses Persist

Trans American Aquaculture reports increased revenue for Q1 2024 compared to the previous year, but continues to operate at a net loss and faces going concern uncertainties.

Summary

• Trans American Aquaculture, Inc. reported its financial results for the first quarter of 2024.
• The company generated revenue of $310,126, a significant increase from $0 in the same period last year.
• However, the company experienced a net loss of $261,873, slightly higher than the $258,194 loss in Q1 2023.
• The company's current liabilities exceed its current assets by $3,750,007 as of March 31, 2024.
• The company has a cash balance of $0 as of March 31, 2024.
• The company's ability to continue as a going concern is dependent on raising additional capital and implementing its business plan.
• The company is in default on a farm property note but has entered into a Forbearance and Modification Agreement with the lender.
• The company is seeking to extend the due date of shareholder notes to January 1, 2025.
• The company signed an unsecured promissory note for $111,600 in February 2024.
• The company put 4,615,277 shares of common stock to GHS at a purchase price of $0.00224 under the EFA for net proceeds of $2,106.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While revenue increased, the company continues to operate at a loss and faces significant financial challenges, including a lack of cash and a going concern uncertainty. The forbearance agreement provides some temporary relief, but the overall outlook is concerning.

Positives

• The company generated revenue of $310,126 in Q1 2024, a significant increase from $0 in the same period last year, indicating progress in commercial operations.
• The company has entered into a Forbearance and Modification Agreement with the lender of the farm property note, providing temporary relief from default.
• The company is actively pursuing additional sources of financing to fund its operations.

Negatives

• The company experienced a net loss of $261,873 in Q1 2024, indicating ongoing financial challenges.
• The company's current liabilities significantly exceed its current assets, raising concerns about its short-term financial stability.
• The company has a cash balance of $0, highlighting its urgent need for additional funding.
• The company is in default on a farm property note, although a forbearance agreement is in place.
• The company's auditors have identified a material weakness in internal control over financial reporting.

Risks

• The company's ability to continue as a going concern is dependent on raising additional capital, which is not guaranteed.
• The company is subject to production risks such as weather and disease, which could affect its ability to generate revenue.
• The company faces competition from imported shrimp, which can affect commodity prices.
• The company's reliance on a single customer for 100% of its revenue creates a concentration risk.
• The company's internal control over financial reporting is not effective due to a material weakness.

Future Outlook

The company anticipates stocking larvae in August 2024 with a planned harvest later in the year. The company will require additional funding to finance the growth of its operations and achieve its strategic objectives. The company is seeking to raise additional capital and is targeting strategic partners to accelerate the sales and marketing of its products and begin generating revenues.

Management Comments

• Management is actively pursuing additional sources of financing sufficient to generate enough cash flow to fund its operations; however, management cannot make any assurances that such financing will be secured.

Industry Context

The report mentions that shrimp prices have dropped as much as 44% since 2022, according to preliminary 2023 data from the National Marine Fisheries Service. This price volatility and increased availability of imported shrimp are significant factors affecting the company's business.

Comparison to Industry Standards

• The company aims to adhere to Best Aquaculture Practices (BAP) guidelines, which are considered a leading standard in the aquaculture industry.
• The company claims to be operating on the largest scale aquaculture farm in the U.S., suggesting a significant production capacity compared to smaller farms.
• The company's focus on producing shrimp free of antibiotics and hormones aligns with a growing consumer demand for sustainable and healthy seafood options.

Legal Proceedings

• The company is involved in lawsuits against the Company involving general liability or various contractual matters.
• In the opinion of the Company's management, the potential claims against the Company not covered by insurance resulting from such litigation will not materially affect the financial position of the Company.

Related Party Transactions

• Shareholders have loaned the Company approximately $1,629,138 in notes which accrue interest ranging from 12% and 18% per annual period.
• Maturities between April 1, 2024 and July 1, 2024, have been extended to December 31, 2024.

Stakeholder Impact

• Shareholders face the risk of dilution due to potential equity offerings.
• Employees' job security is uncertain due to the company's going concern uncertainty.
• Customers may be concerned about the company's ability to consistently supply shrimp due to its financial challenges.
• Creditors face the risk of non-payment due to the company's financial difficulties.

Next Steps

• The company plans to stock larvae in August 2024.
• The company intends to file its 2020 federal tax return and pay the tax due, plus penalties and interest, once it has sufficient cash to do so.
• The company plans to extend the due date of shareholder notes to January 1, 2025.
• The company is working towards full compliance with Best Aquaculture Practices (BAP) guidelines.

Key Dates

Keywords

aquaculture, shrimp farming, financial results, revenue, net loss, going concern, liabilities, assets, notes payable, capital raising